BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9523977)

  • 1. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
    Thomasin C; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations.
    Thomasin C; Hô NT; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):259-68. PubMed ID: 9523976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
    Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
    J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
    Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
    Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
    Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
    J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial solubility parameters of poly(D,L-lactide-co-glycolide).
    Schenderlein S; Lück M; Müller BW
    Int J Pharm; 2004 Nov; 286(1-2):19-26. PubMed ID: 15500999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation on structural integrity of PLGA during ammonolysis-based microencapsulation process.
    Heo S; Lee M; Lee S; Sah H
    Int J Pharm; 2011 Oct; 419(1-2):60-70. PubMed ID: 21839820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A; Burgess DJ
    Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
    Young TJ; Johnston KP; Mishima K; Tanaka H
    J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres.
    Benelli P; Conti B; Genta I; Costantini M; Montanari L
    J Microencapsul; 1998; 15(4):431-43. PubMed ID: 9651865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer.
    Elkheshen S
    J Microencapsul; 1996; 13(4):447-62. PubMed ID: 8808781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.